Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Conbercept”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05414149
What this trial is testing

Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Peking University People's Hospital 80
Testing effectiveness (Phase 2)UnknownNCT02857517
What this trial is testing

Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Who this might be right for
Idiopathic Choroidal Neovascularization
Jiao Mingfei 50
Post-approval studies (Phase 4)Study completedNCT02821520
What this trial is testing

Initial Versus Delayed PDT Combination With Conbercept in PCV

Who this might be right for
Polypoidal Choroidal Vasculopathy
The Eye Hospital of Wenzhou Medical University 80
Not applicableUnknownNCT04627402
What this trial is testing

Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)

Who this might be right for
Diabetes Mellitus, Type 2Macular Edema
Zhongshan Ophthalmic Center, Sun Yat-sen University 50
Testing effectiveness (Phase 2)UnknownNCT05642793
What this trial is testing

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Who this might be right for
Proliferative Diabetic Retinopathy
Peking University Third Hospital 80
Not applicableStudy completedNCT03154892
What this trial is testing

The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma

Who this might be right for
Neovascular Glaucoma
Second Affiliated Hospital of Xi'an Jiaotong University 30
Not applicableUnknownNCT03863535
What this trial is testing

PRP vs PRP+IVC for Severe nPDR

Who this might be right for
Severe Nonproliferative Diabetic RetinopathyDiabetic RetinopathyDiabete Mellitus
Ruijin Hospital 40
Large-scale testing (Phase 3)Ended earlyNCT03577899
What this trial is testing

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 1,157
Testing effectiveness (Phase 2)UnknownNCT04990271
What this trial is testing

A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma

Who this might be right for
Retinoblastoma
Chengdu Kanghong Biotech Co., Ltd. 92
Large-scale testing (Phase 3)Ended earlyNCT04296838
What this trial is testing

Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF

Who this might be right for
UveitisMacular EdemaVascular Endothelial Growth Factor+1 more
Peking Union Medical College Hospital 5
Post-approval studies (Phase 4)Study completedNCT02816710
What this trial is testing

Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic RetinopathyTractional Retinal Detachment
Ruijin Hospital 112
Post-approval studies (Phase 4)Study completedNCT02577107
What this trial is testing

Head to Head Study of Anti-VEGF Treatment.

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 12
Post-approval studies (Phase 4)UnknownNCT03244657
What this trial is testing

Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy

Who this might be right for
Polypoid Choroidal Vasculopathy (PCV)
Chengdu Kanghong Biotech Co., Ltd. 200
Large-scale testing (Phase 3)UnknownNCT02194634
What this trial is testing

Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)

Who this might be right for
Diabetic Macular Edema
Chengdu Kanghong Biotech Co., Ltd. 248
Not applicableUnknownNCT03128463
What this trial is testing

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Who this might be right for
Age-Related Macular DegenerationPolypoidal Choroidal VasculopathyPathological Myopia+2 more
Xun Xu 5,000
Large-scale testing (Phase 3)Study completedNCT03223714
What this trial is testing

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Chengdu Kanghong Biotech Co., Ltd. 242
Not applicableUnknownNCT02911311
What this trial is testing

Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Sun Yat-sen University 226
Post-approval studies (Phase 4)Active Not RecruitingNCT06305143
What this trial is testing

Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Macular Edema
Shanghai Eye Disease Prevention and Treatment Center 58
Not applicableStudy completedNCT05229237
What this trial is testing

Conbercept for Polypoidal Choroidal Vasculopathy（START Study）

Who this might be right for
Polypoidal Choroidal VasculopathyConbercept
Peking Union Medical College Hospital 500
Not applicableUnknownNCT04985448
What this trial is testing

Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data

Who this might be right for
Retinopathy of Prematurity
Chengdu Kanghong Biotech Co., Ltd. 1,000
Next Page